Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dörken

Showing results (1-10 of 243) with videos related to

Pageof 25
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Expression of B-cell-associated antigens during B-cell ontogenyB Dörken
Medizinische Klinik|March 9, 1979
[Classification of malignant non-Hodgkin-lymphoma]B Dörken, W Hunstein
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 20, 2002
[The role of polychemotherapy in the management of malignant bone tumors]P Reichardt, B Dörken
Der Internist|July 13, 2005
[Basics of molecular diagnostics and therapy of malignant tumors]P T Daniel, B Dörken
Experimental Cell Research|April 1, 1978
Ligand-dependent modulation of membrane phospholipid metabolism in ConA-stimulated lymphocytesH Northoff, B Dörken, K Resch
Deutsche Medizinische Wochenschrift (1946)|September 18, 2009
[The molecular pathogenesis of classical Hodgkin lymphoma]S Mathas, B Dörken, M Janz
The Lancet. Oncology|March 22, 2002
Apoptosis: implications of basic research for clinical oncologyI Tamm, F Schriever, B Dörken
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1988
[Non-Hodgkin's lymphoma of low-grade malignancy, to some extent mimicking glomus tumors]A Stiefel, W Hartschuh, B Dörken
Lancet (London, England)|August 22, 2001
Antisense therapy in oncology: new hope for an old idea?I Tamm, B Dörken, G Hartmann
Leukemia|September 28, 2011
Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cellsR Schwarzer, B Dörken, F Jundt
Pageof 25

Showing results (1-10 of 243) with videos related to

Sort By:
Pageof 25
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Expression of B-cell-associated antigens during B-cell ontogenyB Dörken
Medizinische Klinik|March 9, 1979
[Classification of malignant non-Hodgkin-lymphoma]B Dörken, W Hunstein
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 20, 2002
[The role of polychemotherapy in the management of malignant bone tumors]P Reichardt, B Dörken
Der Internist|July 13, 2005
[Basics of molecular diagnostics and therapy of malignant tumors]P T Daniel, B Dörken
Experimental Cell Research|April 1, 1978
Ligand-dependent modulation of membrane phospholipid metabolism in ConA-stimulated lymphocytesH Northoff, B Dörken, K Resch
Deutsche Medizinische Wochenschrift (1946)|September 18, 2009
[The molecular pathogenesis of classical Hodgkin lymphoma]S Mathas, B Dörken, M Janz
The Lancet. Oncology|March 22, 2002
Apoptosis: implications of basic research for clinical oncologyI Tamm, F Schriever, B Dörken
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1988
[Non-Hodgkin's lymphoma of low-grade malignancy, to some extent mimicking glomus tumors]A Stiefel, W Hartschuh, B Dörken
Lancet (London, England)|August 22, 2001
Antisense therapy in oncology: new hope for an old idea?I Tamm, B Dörken, G Hartmann
Leukemia|September 28, 2011
Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cellsR Schwarzer, B Dörken, F Jundt
Pageof 25